Company news

Theraclion SA news in 2025

Theraclion SA's news releases, calls and decks from 2025, newest first.

View company

Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements

December 9, 2025

Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results

October 29, 2025

Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China

October 21, 2025

Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital

October 10, 2025

Theraclion: Sonovein® Receives MDR Certification, Strengthening Its Commercial Potential

September 24, 2025

Theraclion Announces Successful U.S. FDA Pivotal Study With 96.8% Occlusion Rate

September 15, 2025

Theraclion Growth Up in S1 2025

July 25, 2025

Theraclion Announces Financial Results 2024 and Reviews Progress

April 29, 2025

Theraclion Completes Its Previous Financing Round With an Additional Convertible Bonds Issuance

March 26, 2025

Theraclion Secures Financing From Its Historical Shareholders Through a Convertible Bond Loan

February 20, 2025

Theraclion Announces Treatment of First Patients With New SONOVEIN® ‘SpeedPulse’ Feature Accelerating Treatment

February 11, 2025

Theraclion: Publication of Adjusted Accounts for the First Half of 2024

February 7, 2025

Theraclion Reviews Its 2024 Achievements

January 6, 2025

Decks in 2025